Open Access Highly Accessed Research article

Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized controlled trial

Vibeke Strand*, Philip Mease, Gerd R Burmester, Enkeleida Nikaï, Geoffroy Coteur, Ronald van Vollenhoven, Bernard Combe, Edward C Keystone and Arthur Kavanaugh

Arthritis Research & Therapy 2009, 11:R170  doi:10.1186/ar2859

Article Metrics

9739
Total accesses


2
BioMed Central citations

Article metric FAQ

Accesses  

  • Last 30 days: 114 accesses
  • Last 365 days: 2264 accesses
  • All time: 9739 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information